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 Background. There is limited evidence for effective interventions in the treatment of 
posttraumatic stress symptoms within individuals diagnosed with schizophrenia. Clinicians 
have concerns about using exposure treatments with this patient group. The current trial was 
designed to evaluate a 16-session cognitive restructuring programme, without direct 
exposure, for the treatment of posttraumatic stress symptoms specifically within individuals 
diagnosed with schizophrenia.  
 
Method. A multicentre randomized controlled single-blinded trial with assessments at 0 
months, 6-months (post-treatment) and 12 months (follow-up) was conducted. Sixty-one 
participants diagnosed with schizophrenia and exhibiting posttraumatic stress symptoms 
were recruited. Those randomized to treatment were offered up to 16 sessions of cognitive 
behaviour therapy (CBT, including psychoeducation, breathing training and cognitive 
restructuring) over a 6-month period, with the control group offered routine clinical services. 
The main outcome was blind rating of posttraumatic stress symptoms using the Clinician 
Administered PTSD Scale for Schizophrenia (CAPS-S). Secondary outcomes were psychotic 
symptoms as measured by the Positive and Negative Symptom Scale (PANSS) and the 
Psychotic Symptom Rating Scale (PSYRATS).  
 
Results. Both the treatment and control groups experienced a significant decrease in 
posttraumatic stress symptoms over time but there was no effect of the addition of CBT on 
either the primary or secondary outcomes.  
 
Conclusions. The current trial did not demonstrate any effect in favour of CBT. Cognitive 
restructuring programmes may require further adaptation to promote emotional processing of 
traumatic memories within people diagnosed with a psychotic disorder.  
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Introduction 
 
Individuals diagnosed with a psychotic disorder report suffering a high prevalence of 
stressful and traumatic life events (Bebbington et al. 2004) with childhood trauma 
specifically indicated as a risk factor for diagnosis (Matheson et al., 2013). The prevalence of 
posttraumatic stress disorder (PTSD) has been estimated to be aproximately15% within this 
group (Achim et al. 2011; de Bont et al., 2015;  Grubaugh et al., 2011). This co-morbid 
presentation is associated with a poor prognosis and increased use of healthcare (Switzer et 
al. 1999), contributing to calls for the routine assessment of trauma symptoms within the 
psychiatric system (Rose et al., 2012). 
 An increased awareness of the association between stressful life events and the onset 
and maintenance of psychotic symptoms has also contributed to the development of 
theoretical models aimed at informing psychological interventions (e.g. Morrison et al. 2003; 
Read et al. 2014; Steel et al. 2005). One approach is to work towards a cognitive-behavioural 
formulation in which reactions to early trauma are embedded within a developmental 
framework. Links are made between these life events and psychotic experiences such as 
paranoia. On the basis of this formulation, interventions are adopted which target unhelpful 
appraisals driven by core beliefs, such as ‘others are not to be trusted’ (e.g. Smith et al. 
2006).  
 An alternative approach is to adopt a psychological intervention that has been 
established as a treatment for the symptoms of posttraumatic stress within a non-psychotic 
patient population. One such established treatment is cognitive-behavioural therapy for 
PTSD (Foa, 2008) which includes exposure therapy and/or cognitive restructuring. 
Prolonged exposure to the memory of traumatic events in order to elaborate and 
contextualise these memories is a critical component of several evidence-based treatments 
for PTSD (e.g. Clark & Ehlers, 2004; Foa et al., 2005). A recent clinical trial suggests that 
exposure based interventions are effective in individuals diagnosed with a psychotic disorder 
(van den Berg et al. 2015). However, the sensitivity to stress associated with this group 
(Lataster et al., 2013) has led to concern among clinicians about using this approach (Meyer 
et al. 2014). This is a challenge within the delivery of U.K. psychosis services, where only 
10% of eligible service users receive any type of psychotherapy (The Schizophrenia 
Commission, 2012).   
 Clinical studies of participants diagnosed with PTSD but not psychotic disorder 
indicate that cognitive restructuring and exposure are equally effective in supporting 
emotional processing of trauma memory and reduction of PTSD symptoms (Marks, 1998; 
Resnick et al. 2003; Tarrier et al. 1999). Therefore, based on the assumption that cognitive 
restructuring is less stressful than exposure therapy, Mueser and colleagues developed a 
structured cognitive-behavioural program for treating PTSD in individuals exhibiting a range 
of complex presentations, including people diagnosed with schizophrenia, with a primary 
focus on cognitive restructuring (Mueser et al. 2008; Mueser et al. 2015). The 12-16-session 
program includes psychoeducation, breathing training, and cognitive restructuring and has 
been shown to be effective in reducing PTSD symptoms in those diagnosed with severe 
mental health problems in two randomized controlled trial (Mueser et al., 2008; Mueser et al. 
2015). However, these studies contained samples in which the majority of participants had 
severe mood disorders, and less than one-third had a schizophrenia-spectrum disorder. 
Therefore the program needs further investigation to determine its effectiveness for people 
diagnosed with a psychotic disorder, and schizophrenia or schizoaffective disorder in 
particular. This was the aim of the current study. 
 It was hypothesized that CBT in addition to treatment as usual would result in large 
reductions in posttraumatic stress symptoms.  
 
Method 
  
Trial Design 
This was a single-blind randomised controlled trial of CBT vs treatment as usual with a 6-
month treatment phase and a 12-month follow-up phase. Up to 16 sessions of treatment were 
available within the 6-month period, with 6 or more sessions being considered minimal 
exposure to the treatment protocol.  
Robust procedures were adopted to minimize the risk of interviewers being able to 
identify the group allocation of participants. Blind was broken in 10 (6.4%) of the 157 
completed assessments. Of these, 7 (4.5%) assessments were subsequently conducted by a 
new masked interviewer. Three (1.9%) of assessments took place with the mask broken and 
an audio recording was sent to a masked interviewer to conduct the ratings.  
All interviewers were trained for reliability on the CAPS-S and PANSS, and 
subsequently attended monthly meetings in which a trial assessment was rated by all 
interviewers in order to assess for any drift in inter-rater agreements. 
The study was conducted in two large NHS Trusts located in the South of England, 
namely Berkshire Healthcare Foundation Trust (BHFT) and North East London Foundation 
Trust (NELFT). The trial was given ethical approval by Berkshire REC SC/09/H0505/85 and 
was registered as ISTCRN 67096137. 
 
Sample-size calculation 
Power analysis was based on obtaining a reduction of 15 points on the CAPS-S, which 
represents a clinically meaningful change (Weather et al., 2001). Using a conservative 
estimate of the standard deviation of the change score (SD=15) derived from a previous 
study (Rosenberg et al. 2004), and assuming that mean scores in the TAU group do not 
change over the treatment period, a mean reduction of 15 points in the CBT group translates 
into a large effect size (d=1). To detect such an effect, or a larger one, using an independent 
samples t-test at the conservative 5% significance level (two-tailed) with 95% power, a 
sample size of 26 per group would be needed. Assuming a 15% drop-out rate, a sample of 31 
patients per group was required. 
 
Participants 
Participants were eligible if they were aged between 18 and 65, had stable living 
arrangements, met DSM-IV (American Psychiatric Association, 1994) criteria for 
schizophrenia, schizoaffective disorder or schizophreniform disorder, and met DSM-IV 
criteria for PTSD. Exclusion criteria were organic impairment or insufficient command of 
English. 
 
Measures 
Screening 
History of trauma exposure was evaluated with the Trauma History Questionnaire (THQ; 
Green, 1996), which has been previously adapted for use with people with severe mental 
health problems (Mueser et al., 2008). The original 16-item version was extended to include 
two extra items relevant to the current population, namely psychiatric treatment and 
psychotic experiences which were experienced as a threat to the self (see Picken & Tarrier, 
2011). Eligibility was initially assessed using a brief self-report measure, the Posttraumatic 
Stress Disorder Checklist, Civilian version (PCL-C, (Blanchard et al., 1996)) which contains 
17 items on a 5-point scale (range 17-85). 
 
Primary Outcome 
PTSD symptom severity was assessed with the Clinician Administered PTSD Scale for 
Schizophrenia (CAPS-S; Gearon et al, 2004). The CAPS-S is an adapted version of the 
CAPS (Blake et al. 1995) which has been shown to be reliable and valid when used with 
people diagnosed with severe mental health problems (Mueser et al. 2001). For each 
symptom, a frequency and intensity rating is provided, with overall severity scores computed 
by summing the frequency and intensity scores for all of the PTSD symptoms (CAPS–Total).  
 
Secondary outcome 
Positive symptoms of psychosis were assessed with the Positive and Negative Syndrome 
Scale  (PANSS, Kay et al. 1987). The PANSS includes items measuring positive symptoms, 
negative symptoms, and other symptoms, and is used widely in research with people 
daignosed with schizophrenia..  
 
Other measures  
Severity of hallucinations and delusions were assessed using the Psychotic Symptom 
Rating Scale (PSYRATS, Haddock et al. 1999).  
Trauma-related cognitions were assessed with the Posttraumatic Cognitions Inventory 
(PTCI, Foa et al. 1999), a self-report measure of common negative beliefs about oneself, 
other people, and the world, which relate to traumatic experiences. Greater endorsement of 
negative beliefs is indicated by a high score.  
Depression and anxiety were rated with the Beck Depression Inventory (BDI-II; Beck et al. 
1996) and the Beck Anxiety Inventory (BAI; Beck & Steer, 1990).  
Functioning was assessed using the Global Assessment of Functioning (GAF; Hall, 1995) 
which produces a rating from 0 to 100, with a high score indicating higher functioning.  
Quality of Life was measured using the Quality of Life (QLS) scale (Heinrichs et al. 1984). 
 
Procedures 
Recruitment was conducted by trained research assistants and clinical studies officers from 
the NIHR Clinical Research Network Mental Health at both sites. Recruitment was 
systematic with each mental health team responsible for a geographical location being 
approached in turn. Research assistants contacted all care coordinators in order to identify 
potentially eligible participants.  
When individuals provided consent, research assistants then checked health care 
records to assess eligibility in relation to primary diagnosis and demographics. The modified 
THQ was then completed with potential participants identifying which event was currently 
associated with the most distress. The PCL-C was then completed in relation to that event. If 
an individual scored 44 or higher they were invited to complete a clinical interview to assess 
the symptoms of PTSD with the CAPS-S.  
Recruitment commenced in May 2010 with an entry criterion of diagnostic PTSD. 
Due to lower than anticipated recruitment rates, in May 2011 the CAPS-S entry criterion was 
amended to include those who fulfilled criteria A (event), B (intrusive symptoms), E (time 
duration) and F (functional impairment) but not necessarily criterion C (avoidance) or D 
(hyperarousal). Traumatic events related to psychosis were not required to meet criterion A 
(objective physical threat) for eligibility, although a subjective perception of threat to self or 
others was present. A maximum of 4 separate traumas were assessed using the CAPS-S 
within any potential participant in order to determine eligibility.  
 Eligible participants were randomised immediately after the completion of baseline 
assessments. Block randomisation was conducted independently of the research team 
through the OpenCDMS database specifically developed for the study and was stratified for 
site and PTSD symptom severity (CAPS-S  ≥ 65). 
 
Interventions 
CBT for PTSD. The intervention followed the protocol adopted in previous trials (see 
Mueser et al., 2008) with minor adaptations made for use in the U.K. The 12-16 session 
programme followed a structured format and included handouts, worksheets and homework 
assignments. All sessions were conducted at the clients’ local community mental health 
centre or at their home. There was regular contact and coordination between trial therapists 
and NHS treatment teams. Individuals allocated to CBT also received the routine clinical 
services available to the TAU (Treatment as Usual) group. 
 TAU. Clients assigned to TAU continued to receive the usual services available to them 
through their clinical teams. Type and dose of medication was determined by NHS 
clinicians, and was not affected by the trial protocol.  
 
Trial Therapists 
There were thirteen trial therapists comprised of 7 clinical psychologists, 3 BABCP 
accredited CBT therapists, 2 counselling psychologists and 1 trainee clinical psychologist. 
Of the 30 cases allocated to treatment, 23 (77%) were seen by clinicians with over 5 years 
experience of delivering psychological interventions with individuals diagnosed with 
psychosis, 3 (10%) by clinicians with one to five years experience and 4 (13%) by clinicians 
with less than one years experience. Training in the trial protocol was delivered by JG over a 
2-day period. Ongoing fortnightly supervision was delivered by BS and AH for all therapists. 
Overall, 25% of recorded sessions were assessed using a measure of competence and 
adherence and were judged to be of at least an adequate level.  
 
Statistical Analysis 
To allow for correlation between the post-treatment and follow-up value of the same 
variable, linear mixed (covariance pattern) models with unstructured covariance matrices 
were fitted using SAS PROC MIXED. Otherwise known as marginal models, this approach 
is equivalent to fitting models with random intercepts that vary at the level of study 
participants. Maximum likelihood estimation procedures ensure that inferences will remain 
valid in the presence of missing data, provided the missing value generating mechanism is 
missing at random (not missing completely at random) and is therefore a less restrictive 
approach than the conventional complete case analysis. Analyses were adjusted for baseline 
response, whether or not inclusion in the study was based on the initial eligibility criteria and 
for the randomisation stratifier (CAPS-S severity with a cut-off at 65) by including these as 
fixed explanatory variables in the models. Time and treatment-by-time interaction terms 
were retained in all models and group differences estimated at each post randomisation time 
point. Residual diagnostics were conducted to check violation of normality assumptions. 
Post treatment and follow up effect sizes based on adjusted treatment means, are computed 
using Cohen’s d along with 95% confidence intervals. The same approach was adopted for 
the main outcome (CAPS-S) as for the secondary outcome (PANSS positive) and the other 
outcome measures.  
 
Results 
Sample characteristics 
In total 1,465 referrals were provided for the trial, of whom 209 gave consent to be assessed 
and 61 were eligible. See Fig.1 for the trial CONSORT (Consolidated Standards of 
Reporting Trials) diagram. The characteristics of the participants allocated to CBT and TAU 
are summarized in Table 1. The two trial arms were similar in terms of diagnostic, 
demographic and baselines measures.  
The most commonly reported traumatic events associated with eligibility was the 
experience of a distressing psychotic episode (n=11, 18%) and sexual abuse whilst under the 
age of 16 (n=11, 18%). A range of other events were reported, with none being experienced 
by more than 10% of the sample. 
For those allocated to the CBT group, the mean number of therapy sessions was 12.3 
(range = 0-16, SD=5.3). Twenty-one participants (70%) received the full protocol of 12 
sessions or more and 26 (87%) received at least 6 sessions, which is considered minimal 
exposure to the intervention (Mueser et al., 2015). 
 
Outcome measures  
There was no significant difference between the intervention and control group in the 
primary outcome of PTSD symptoms on the CAPS-S at the end of treatment (p>0.1, 
between-group d = -0.26 (-0.84, 0.32)), or in the secondary outcome of the positive 
symptoms on PANSS positive (p>0.1, between-group d = 0.32 (-0.26, 0.91)). There were no 
significant differences between groups within any of the other outcome measures (see Table 
2). 
 Although there was no significant difference between the treatment and control 
groups regarding the main outcome of PTSD symptoms, the severity of the posttraumatic 
stress symptoms declined within the combined group over the 12-month period (CBT: 
F=4.41; p<0.01; TAU: F=8.51; p<0.01).  
 
Conclusion 
 
The current study is one of only two published clinical trials that have aimed to evaluate the 
effectiveness of an evidence-based psychological intervention for PTSD solely within 
individuals diagnosed with a psychotic disorder. Our results do not provide evidence for 
cognitive restructuring with no direct exposure, the protocol adopted in the current study, 
reducing the symptoms of PTSD or psychosis beyond that achieved through treatment as 
usual within this group. Eighty-seven percent of individuals allocated to treatment received a 
‘dose’ of the protocol (i.e. at least 6 sessions). Treatment delivery data combined with the 
high level of methodological rigour as regards blind assessments, randomisation procedures 
and data analysis suggests that the non-significant outcome is a valid result. The confidence 
intervals of the effect size suggest that there is less than a 5% chance of the ‘true’ effect size 
being above 0.32. This result should be considered within the context of meta-analyses 
which suggest the overall effect size of generic CBT for psychosis to be in the region of 0.4 
(Wykes et al. 2008; van der Gaag et al. 2014).  
 Given that Mueser et al. (2008, 2015) report that a cognitive restructuring 
intervention is effective for a heterogeneous sample suffering from a range of severe mental 
health problems, it is important to consider any methodological differences between these 
trials and the current study.  
First, unlike Mueser et al. (2008, 2015), the current study included individuals 
suffering from posttraumatic stress symptoms but who did not exhibit a fully diagnostic level 
of PTSD. Therefore, further analyses were conducted excluding the participants within the 
current sample who did not present with a diagnostic level of PTSD symptoms. There was no 
effect of treatment within this fully diagnostic subgroup (see Table 2). Although the small 
sample size limits the reliability of this post-hoc analyses, the result is in line with a recent 
meta-analysis which indicates that the Mueser et al (2008, 2015) studies did not produce a 
significant treatment effect within the subgroup of their samples which were diagnosed with 
schizophrenia (Sin & Spain, 2016). However, it should be noted that the majority of 
participants in the Mueser et al. studies were diagnosed with severe levels of PTSD (i.e. a 
CAP-S score above 65), whilst the current study did not recruit enough participants in this 
subgroup in order to conduct meaningful analysis. Therefore, our study does not exclude the 
possibility of the cognitive restructuring programme being effective with this more severe 
group. 
Second, the current study included psychotic experiences and psychiatric treatment as 
potentially eligible stressful life events whereas Mueser et al (2008, 2015) did not. Eleven 
participants were eligible on the basis of their reaction to a past psychotic episode although 
none were eligible in relation to psychiatric treatment. Whilst the concept of post-psychotic 
PTSD has gained validity (Mueser et al., 2010), specific traumatic events may be associated 
with distinct responses to a psychological intervention. However, further post-hoc analyses 
in which these eleven participants were excluded revealed a non-significant treatment effect 
(see Table 2).  
 Both the intervention and control groups showed a significant reduction in PTSD 
symptoms over the 12-month study period. Van den Berg et al., (2015) also report a 
reduction (16 points) in the CAPS ratings of individuals who did not receive a psychological 
treatment within a 12-month period. These results are inconsistent with data indicating that 
co-morbid PTSD is indicative of a poor prognosis within individuals diagnosed with a 
psychotic disorder (Switzer et al. 1999). One possibility is that individuals who consent for 
treatment within a clinical trial are a ‘help-seeking’ subgroup and may not be representative 
of a wider clinical group exhibiting the same symptom profile. Another possibility is that the 
symptoms of posttraumatic stress may fluctuate over time. Therefore, a portion of the current 
sample may have entered the clinical trial at a more severe stage of a cyclical presentation 
and would experience a subsequent drop in symptoms whether or not they received an 
intervention. It is of note that the test-retest reliability of the CAPS when used with people 
diagnosed with severe mental health problems increases in line with the severity of PTSD 
symptoms (Mueser et al, 2001), suggesting that symptom fluctuation is more likely to occur 
within the non-severe group which are the majority within the current study. This effect is 
likely to have contributed to the unexpected significant reduction of symptoms within the 
control group. It is therefore a limitation of the current trial that the stability of posttraumatic 
stress symptoms were not assessed over a period of time before eligibility was confirmed.  
 Our aim was to evaluate the effectiveness of cognitive restructuring for the treatment 
of posttraumatic stress symptoms specifically within individuals diagnosed with 
schizophrenia. Our results do not provide evidence for the use of this intervention within this 
group. A recently published process analysis based on recordings of the intervention sessions 
from the current study suggests that, whilst engagement remained high, the level of 
emotional processing may not have been sufficient to support adaptation to trauma memories 
and reductions in PTSD symptoms (O’Driscoll et al., 2016). Therefore, cognitive 
restructuring programmes may require further adaptation to promote emotional processing of 
traumatic memories within people diagnosed with a psychotic disorder.  
 To conclude, the current results to not provide support for the use of a cognitive 
restructuring alone for the treatment of posttraumatic symptoms within people diagnosed 
with schizophrenia. However, given that the Mueser et al. (2015) study was targeted 
specifically at individuals suffering from severe levels of PTSD, it may be that such an 
approach is effective within the severe subgroup. However, any future research would 
benefit from an adapted protocol. Therefore, despite anxiety within some mental health 
professionals, current evidence indicates that exposure is required in order to treat trauma 
symptoms within this group. The positive symptoms of psychosis may be exacerbated by the 
presence of decontextualiased intrusive memories, such that trauma memories may need to 
be directly retrieved and elaborated in order for the symptoms of posttraumatic stress to 
reduce (Longden et al., 2012; Steel, 2015; Steel et al., 2005). This conclusion would be 
consistent with the positive results recently obtained using direct memory exposure 
interventions (Prolonged Exposure and EMDR) for the treatment of PTSD in psychotic 
disorder (van den Berg et al. 2015).  
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